BBA
RARX
Baker Bros. Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,093,839
| Closed | -$101M | – | 123 |
|
|
2020
Q1 | $101M | Hold |
2,093,839
| – | – | 0.62% | 17 |
|
|
2019
Q4 | $98.3M | Sell |
2,093,839
-251,657
| -11% | -$11.8M | 0.52% | 20 |
|
|
2019
Q3 | $55.5M | Buy |
2,345,496
+543,801
| +30% | +$12.9M | 0.38% | 22 |
|
|
2019
Q2 | $54.2M | Buy |
1,801,695
+978,582
| +119% | +$29.4M | 0.37% | 29 |
|
|
2019
Q1 | $18.4M | Hold |
823,113
| – | – | 0.12% | 37 |
|
|
2018
Q4 | $15M | Buy |
823,113
+645,161
| +363% | +$11.7M | 0.12% | 42 |
|
|
2018
Q3 | $3.22M | Hold |
177,952
| – | – | 0.02% | 82 |
|
|
2018
Q2 | $1.77M | Hold |
177,952
| – | – | 0.01% | 96 |
|
|
2018
Q1 | $945K | Hold |
177,952
| – | – | 0.01% | 102 |
|
|
2017
Q4 | $1.51M | Hold |
177,952
| – | – | 0.01% | 101 |
|
|
2017
Q3 | $2.6M | Hold |
177,952
| – | – | 0.02% | 91 |
|
|
2017
Q2 | $3.34M | Hold |
177,952
| – | – | 0.03% | 73 |
|
|
2017
Q1 | $3.79M | Hold |
177,952
| – | – | 0.03% | 73 |
|
|
2016
Q4 | $2.7M | Buy |
+177,952
| New | +$2.7M | 0.03% | 82 |
|